DK440989D0 - Dopamin-beta-hydroxylase inhibitorer - Google Patents

Dopamin-beta-hydroxylase inhibitorer

Info

Publication number
DK440989D0
DK440989D0 DK440989A DK440989A DK440989D0 DK 440989 D0 DK440989 D0 DK 440989D0 DK 440989 A DK440989 A DK 440989A DK 440989 A DK440989 A DK 440989A DK 440989 D0 DK440989 D0 DK 440989D0
Authority
DK
Denmark
Prior art keywords
dopamine
beta
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
DK440989A
Other languages
English (en)
Other versions
DK440989A (da
Inventor
Lawrence Ivan Kruse
Joseph Alan Finkelstein
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of DK440989D0 publication Critical patent/DK440989D0/da
Publication of DK440989A publication Critical patent/DK440989A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK440989A 1988-09-12 1989-09-06 Dopamin-beta-hydroxylase inhibitorer DK440989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24338788A 1988-09-12 1988-09-12

Publications (2)

Publication Number Publication Date
DK440989D0 true DK440989D0 (da) 1989-09-06
DK440989A DK440989A (da) 1990-03-13

Family

ID=22918575

Family Applications (1)

Application Number Title Priority Date Filing Date
DK440989A DK440989A (da) 1988-09-12 1989-09-06 Dopamin-beta-hydroxylase inhibitorer

Country Status (5)

Country Link
EP (1) EP0359505A1 (da)
JP (1) JPH02115179A (da)
AU (1) AU4121089A (da)
DK (1) DK440989A (da)
PT (1) PT91697A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039385A1 (es) 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TW200804383A (en) 2006-06-05 2008-01-16 Astrazeneca Ab New compounds
US10689367B2 (en) * 2016-11-16 2020-06-23 Amgen Inc. Triazole pyridyl compounds as agonists of the APJ receptor
MA52487A (fr) 2018-05-01 2021-03-10 Amgen Inc Pyrimidinones substituées en tant qu'agonistes du récepteur apj

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives

Also Published As

Publication number Publication date
PT91697A (pt) 1990-03-30
DK440989A (da) 1990-03-13
AU4121089A (en) 1990-03-15
EP0359505A1 (en) 1990-03-21
JPH02115179A (ja) 1990-04-27

Similar Documents

Publication Publication Date Title
DK66889A (da) Haeveseng
BR8900885A (pt) Pa aerofolica
ATA901789A (de) Somatostatinpeptid
DK233989D0 (da) Mejetaerskerskaerebord
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
BR8907457A (pt) Inibidores de interleucina-1
DK591189D0 (da) Lamelportfloej
DK293088A (da) Inhibitorer af dopamin-beta-hydroxylase
FI101796B1 (fi) Uusia -glukosidaasi-inhibiittoreita
DK163088D0 (da) Dopamin-beta-hydroxylase inhibitor
DK440989A (da) Dopamin-beta-hydroxylase inhibitorer
DK440887D0 (da) Dopamin-beta-hydroxylase-inhibitorer
DK69489A (da) Aspartattranscarbamylase-inhibitorer
KR900004589U (ko) 장기
DK697888A (da) Svingningskompensator
KR890020494U (ko) 담배 파이프
DK95189D0 (da) Muffe
DK178788D0 (da) Inhibitorer af dopamin-beta-hydroxylase
NO881638D0 (no) Dopamin-beta-hydroksylase-inhibitorer.
SE8801231D0 (sv) New use
SE8801179D0 (sv) New use
IS3338A7 (is) Torleiði-seinkunarlína
IE882030L (en) Dopamine-beta-hydroxylase inhibitors
IE880860L (en) Dopamine-beta-hydroxylase inhibitors

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment